Clinical trial
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic Congenital Heart Disease - A Prospective Randomized Control Trial
NCT02564796 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic Congenital Heart Disease - A Prospective Randomized Control Trial
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2016
- Completion date
- June 30, 2020
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.